Experimental validation showed that the expression of these candidate genes was directly regulated through an m6A-dependent mechanism, and inhibition of METTL3 enhances anti-tumor immunity, T cell activation, exhaustion, and infiltration in vitro. The gene discussed is METTL3; the disease is neoplasm.